“Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients”, Reumatismo, vol. 64, no. 6, pp. 368–373, Dec. 2012, doi: 10.4081/reumatismo.2012.368.